[Sodium metabolism in essential hypertension. Renin subgroups and changes of urinary sodium excretion caused by furosemide]. 1975

H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
August 1984, Klinische Wochenschrift,
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
January 1982, Clinical and experimental hypertension. Part A, Theory and practice,
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
January 1993, Nephron,
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
January 1983, Clinical and experimental hypertension. Part A, Theory and practice,
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
March 1978, The Tohoku journal of experimental medicine,
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
October 1976, Angiology,
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
January 1986, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
December 1980, Clinical science (London, England : 1979),
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
April 1979, The Journal of clinical endocrinology and metabolism,
H Memezawa, and K Abe, and N Irokawa, and H Chiba, and M Yasujima
January 1987, Nephron,
Copied contents to your clipboard!